CARA THERAPEUTICS revenue breakdown overview

CARA THERAPEUTICS revenue for the last year amounted to 17.65 M CHF, the most of which — 17.65 M CHF — came from its highest performing source at the moment, Difelikefalin-based Product, the year earlier bringing 38.72 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought CARA THERAPEUTICS 17.65 M CHF, and the year before that — 38.72 M CHF.